White & Case advises FutureLife on acquisition of The Centre for Reproductive and Genetic Health
1 min read
Global law firm White & Case LLP has advised FutureLife, a pan-European provider of IVF and related services, on its acquisition of London IVF clinic The Centre for Reproductive and Genetic Health (CRGH).
Headquartered in the Czech Republic and with investment from CVC Capital Partners and Hartenberg Holding, FutureLife is a pan-European provider of IVF and related genetics services, with 42 clinics across eight European markets including the Czech Republic, Ireland, Netherlands, Romania and Estonia. FutureLife is focused on expanding in a number of key European geographies, including the UK where FutureLife currently has a footprint through London-based City Fertility. Following the acquisition of CRGH, FutureLife will operationally align City Fertility and CRGH to enable knowledge sharing and implementation of best practices across both clinics.
CRGH is the largest private fertility clinic in the London private IVF market. It is located near Harley Street and has been providing IVF treatments for over 30 years.
In December 2021 White & Case advised CVC on its investment in FutureLife a.s., alongside FutureLife's existing investor Hartenberg.
The White & Case team which advised on the transaction was led by partners Steven Worthington (Abu Dhabi and London) and Ben von Maur (London) with support from partners Jan Linda (Prague), Martin Forbes, Marc Israel, Tim Hickman, Helen Joseph, Philip Trillmich, Victoria Landsbert, James Johnson, Clare Connellan, Will Smith, Jonah Anderson (all London) and Sara Nordin (Brussels) and associates Adnan Bekdur, Samantha Shaw (Dubai), Disha Chandrachud, Anna Rawlence, Valeriya Anopchenko, Aishwarya Jha, Shehnai Arora, Kristen DiLemmo, Harriet Baldwin, Vishnu Rege, Kate Curran, Grace Williams, Yannis Lagdani, Laura Higgins and Mhairi Fraser (all London).
For more information please speak to your local media contact.